CDKN2A and melanoma: Although the onset of melanoma at a young age is quite common in subjects carrying CDKN2A mutations, it cannot be considered a predictor of the presence of the mutation; less than 1% of individuals diagnosed with melanoma before the age of 40 age are, in fact, positive for this mutation [6].